China’s healthcare market is one of the largest in the world. The market for pharmaceuticals and biopharmaceuticals is growing steadily due to the unbridled demand for innovative drugs and diagnostics as well as conventional drugs and generics.
German products are in demand in China, which opens up good business opportunities for local manufacturers. At the same time, the Chinese market is highly regulated. Complex registration and approval procedures, strict regulations on pricing and distribution make it difficult to get started. The study describes the most important aspects of market access for pharmaceuticals and biopharmaceuticals, introduces China’s business culture, makes recommendations for successful market development and provides information on key local partners.
The publication was commissioned by the Export Initiative for the Healthcare Industry and published by Germany Trade & Invest.
You can download the publication here
Source: Federal Ministry for Economic Affairs and Energy of 10.09.2021